Status:
COMPLETED
Retrospective Review on Patients With Culture Negative Empyema
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Empyema, Pleural
Eligibility:
All Genders
18+ years
Brief Summary
Empyema is associated with a wide range of complication and mortality. It is defined by either a positive pleural fluid culture or grossly pus appearance. However, little is known about the difference...
Detailed Description
Pneumonia is a common disease and it ranked second as the leading cause of death in Hong Kong in 2016. Among patients suffering from acute pneumonia, up to 57% of them would develop parapneumonic effu...
Eligibility Criteria
Inclusion
- i. All patients hospitalized for empyema, defined by the presence of purulent pleural fluid or positive culture result from pleural fluid ii. Age greater than 18 years old
Exclusion
- i. Inappropriate diagnosis of empyema after evaluation ii. Tuberculous pleuritis, defined by presence of Mycobacterium tuberculosis culture from pleural fluid or granulomatous inflammation on pleural biopsy histology
Key Trial Info
Start Date :
May 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2020
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT04477980
Start Date
May 3 2018
End Date
May 31 2020
Last Update
July 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese University of Hong Kong
Hong Kong, Hong Kong